ENDOTHELIAL GLYCOCALYX — POTENTIAL VASCULAR BIOMARKER: DIAGNOSTIC AND THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASES
https://doi.org/10.15829/1728-8800-2015-6-87-92
Abstract
Endothelium glycocalyx (EG) is a highly organized protecting complex of the vessels. Damage of EG is one of the first pathogenetic mechanisms of a range of pathologies onset, and primarily cardiovascular diseases. Current paper focuses on the structure, functioning of EG normally and in pathology, and on the possibility to apply EG as potential vascular biomarker, target for therapy.
About the Authors
A. Yu. Gorshkov
National Research Center for Preventive Medicine of the Ministry of Health, Moscow
Russian Federation
Russian Federation
S. A. Boytsov
National Research Center for Preventive Medicine of the Ministry of Health, Moscow
Russian Federation
Russian Federation
References
1. WHO Global InfoBase (http:www.infobase.who.int).
2. Oganov RG, Maslennikova GYa. Demographic trends in the Russian Federation: the impact of cardiovascular disease. Cardiovascular Therapy and Prevention 2012; 11(1): 5-10. Russian (Oganov R.G., Maslennikova G.Ya. Demograficheskie tendentsii v Rossiiskoi Federatsii: vklad boleznei sistemy krovoobrashcheniya. Kardiovaskulyarnaya terapiya i profilaktika 2012; 11(1): 5-10).
3. National guidelines for cardiovascular prevention. Cardiovascular Therapy and Prevention 2011; 10 (6) Suppl 2: 1-64. Russian (Natsional'nye rekomendatsii po kardiovaskulyarnoi profilaktike. Kardiovaskulyarnaya terapiya i profilaktika 2011; 10(6) Prilozhenie 2: 1-64).
4. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007; 9: 121-67.
5. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 71(2): 481-539.
6. Oohira A, Wight TN, Bornstein P. Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem 1983; 258 (3): 2014-21.
7. Gandhi NS, Mancera RL. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 2008; 72(6): 455-82.
8. Squire JM, Chew M, Nneji G, et al. Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? J Struct Biol 2001; 136 (3): 239-55.
9. Weinbaum S, Zhang X, Han Y, et al. Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci USA 2003; 100 (13): 7988-95.
10. Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc 1966; 25(6): 1773-83.
11. Rostgaard J, Qvortrup K. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res 1997; 53(1): 1-13.
12. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res 2003; 92(6): 592-4.
13. Henry CB, Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 1999; 277 (2 Pt 2): H508-14.
14. van Haaren PM, VanBavel E, Vink H, et al. Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. Am J Physiol Heart Circ Physiol 2003; 285(6): H2848-56.
15. Ueda A, Shimomura M, Ikeda M, et al. Effect of glycocalyx on shear-dependent albumin uptake in endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287 (5): H2287-94.
16. Van Haaren PM, VanBavel E, Vink H, et al. Charge modification of the endothelial surface layer modulates the permeability barrier of isolated rat mesenteric small arteries. Am J Physiol Heart Circ Physiol 2005; 289(6): H2503-7.
17. Beresewicz A, Czarnowska E, Maczewski M. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig heart. Mol Cell Biochem 1998; 186(1-2): 87-97.
18. Ward BJ, Donnelly JL. Hypoxia induced disruption of the cardiac endothelial glycocalyx: implications for capillary permeability. Cardiovasc Res 1993; 27(3): 384-9.
19. Constantinescu AA, Vink H, Spaan JA. Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am J Physiol Heart Circ Physiol 2001; 280(3): H1051-7.
20. Weinbaum S. 1997 Whitaker Distinguished Lecture: Models to solve mysteries in biomechanics at the cellular level; a new view of fiber matrix layers. Ann Biomed Eng 1998; 26(4): 627-43.
21. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100(5): 1211-23.
22. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 1996; 79(3): 581-9.
23. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer. Implications for platelet-endothelial cell adhesion. Circulation 2000; 101(13): 1500-2.
24. Pries AR, Secomb TW, Jacobs H, et al. Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol 1997; 273 (5 Pt 2): H2272-9.
25. Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454(3), 345-59.
26. Constantinescu AA, Vink H, Spaan JA. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 2003; 23(9):1541-7.
27. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000; 279 (6): H2815-23.
28. Scientific and technical encyclopedic dictionary. gufo.me/content_naukteh naprjazhenie-sdviga-61437.html. Russian (Nauchno-tekhnicheskii entsiklopedicheskii slovar'). gufo.me/content_naukteh/naprjazhenie-sdviga-61437.html.
29. Melkumyants AM, Balashov SA. The mechanosensing of arteries endothelium. Tver’: Izdatel’stvo “Triada” 2005; 208 p. Russian (Mel'kumyants A.M., Balashov S.A. Mekhanochuvstvitel'nost' arterial'nogo endoteliya. Tver': Izdatel'stvo “Triada” 2005; 208 s).
30. Jacob M, Rehm M, Loetsch M, et al. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J Vasc Res 2007; 44(6): 435-43.
31. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70(2): 181-90.
32. Florian JA, Kosky JR, Ainslie K, et al. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 2003; 93(10): e136-42.
33. Wilsie LC, Orlando RA. The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J Biol Chem 2003; 278(18): 15758-64.
34. Perrimon N, Bernfield M. Specificities of heparin sulphate proteoglycans in developmental processes. Nature 2000; 404 (6779): 725-8.
35. Egbrink MG, Van Gestel MA, Broeders MA, et al. Regulation of microvascular thromboembolism in vivo. Microcirculation 2005; 12(3): 287-300.
36. Kumagai R, Lu X, Kassab GS. Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species. Free Radic Biol Med 2009; 47(5): 600-7.
37. Noble MI, Drake-Holland AJ, Vink H. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM 2008; 101(7): 513-8.
38. Vlachopoulos S, Xaplanteris P, Aboyans P, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 2015; 241(2): 507-32.
39. Lekakis J, Abraham P, Balbarini A, et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation, Eur J Cardiovasc Prev Rehabil 2011; 18 (6): 775-89.
40. Nieuwdorp M, Meuwese MC, Mooij HL, et al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol 2008; 104(3): 845-52.
41. Vlahu SA, Lemkes BA, Struijk DG, et al. Damage of the Endothelial Glycocalyx in Dialysis Patients. J Am Soc Nephrol 2012; 23(11): 1900-8.
42. Groen BB, Hamer HM, Snijders T, et al. Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes. J Appl Physiol 2014; 116(8): 998-1005.
43. Donati A, Damiani E, Luchetti M, et al. Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care 2014; 18 (1): R33.
44. Mulders TA, Nieuwdorp M, Stroes ES, et al. Noninvasive assessment of microvascular dysfunction in families with premature coronary artery disease. Int J Cardiol 2013; 168(5): 5026-8.
45. Amraoui F, Olde Engberink RH, van Gorp J, et al. Microvascular glycocalyx dimension estimated by automated SDF imaging is not related to cardiovascular disease. Microcirculation 2014; 21(6): 499-505.
46. Martens RJ, Vink H, van Oostenbrugge RJ, et al. Sublingual microvascular glycocalyx dimensions in lacunar stroke patients. Cerebrovasc Dis 2013; 35(5): 451-4.
47. Broekhuizen LN, Lemkes BA, Mooij H, et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type II diabetes mellitus. Diabetologia 2010; 53(12): 2646-55.
48. Meuwese MC, Mooij HL, Nieuwdorp M, et al. Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia. J Lipid Res 2009; 50(1): 148-53.
49. Maksimenko AV, Turashev AD, Fedorovich AA, et al. Flowmetric study with hyaluronidase and chondroitin sulfate demonstrates the partaking of endothelial glycocalyx in microcirculation disturbances. The Journal of Atherosclerosis and Dyslipidemias 2011; 3: 13-29. Russian (Maksimenko A.B., Turashev A.D., Fedorovich A.A., i dr. Endotelial'nyi glikokaliks krys uchastvuet v narusheniyakh mikrotsirkulyatornogo rusla. Ateroskleroz i dislipidemii 2011; 3: 13-29).
Review
For citations:
Gorshkov A.Yu., Boytsov S.A. ENDOTHELIAL GLYCOCALYX — POTENTIAL VASCULAR BIOMARKER: DIAGNOSTIC AND THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASES. Cardiovascular Therapy and Prevention. 2015;14(6):87-92. (In Russ.) https://doi.org/10.15829/1728-8800-2015-6-87-92
Views:
2299
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
